TC regimen

WikiDoc Resources for TC regimen

Articles

Most recent articles on TC regimen

Most cited articles on TC regimen

Review articles on TC regimen

Articles on TC regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on TC regimen

Images of TC regimen

Photos of TC regimen

Podcasts & MP3s on TC regimen

Videos on TC regimen

Evidence Based Medicine

Cochrane Collaboration on TC regimen

Bandolier on TC regimen

TRIP on TC regimen

Clinical Trials

Ongoing Trials on TC regimen at Clinical Trials.gov

Trial results on TC regimen

Clinical Trials on TC regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on TC regimen

NICE Guidance on TC regimen

NHS PRODIGY Guidance

FDA on TC regimen

CDC on TC regimen

Books

Books on TC regimen

News

TC regimen in the news

Be alerted to news on TC regimen

News trends on TC regimen

Commentary

Blogs on TC regimen

Definitions

Definitions of TC regimen

Patient Resources / Community

Patient resources on TC regimen

Discussion groups on TC regimen

Patient Handouts on TC regimen

Directions to Hospitals Treating TC regimen

Risk calculators and risk factors for TC regimen

Healthcare Provider Resources

Symptoms of TC regimen

Causes & Risk Factors for TC regimen

Diagnostic studies for TC regimen

Treatment of TC regimen

Continuing Medical Education (CME)

CME Programs on TC regimen

International

TC regimen en Espanol

TC regimen en Francais

Business

TC regimen in the Marketplace

Patents on TC regimen

Experimental / Informatics

List of terms related to TC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Taxotere-Cyclophosphamide regimen

## Overview

[edit | edit source]

TC regimen refers to a regimen consisting of docetaxel and cyclophosphamide used to treat breast cancer.[1]

## Regimen

[edit | edit source]

TDocetaxel (Taxotere)

CCyclophosphamide (Cytoxan)

## Indications

[edit | edit source]

* Breast cancer[1]

## References

[edit | edit source]

1. ↑ 1.0 1.1 Jones SE, Savin MA, Holmes FA, O'Shaughnessy JA, Blum JL, Vukelja S; et al. (2006). "Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer". J Clin Oncol. 24 (34): 5381–7. doi:10.1200/JCO.2006.06.5391. PMID 17135639.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)